The ADVIA 2120 Hematology System combines real world convenience and practical automation, building on the proven technological productivity of the ADVIA® 120 Hematology System.
The system features fully automated testing capability for some of the most labor intensive blood tests in the world today; such as cerebral spinal fluid (CSF) analysis which has increased due to the onset of the West Nile Virus, reticulocytes for monitoring anemia, as well as, the commonly requested complete blood count.
"With the introduction of this technology into my laboratory, we were able to decrease our review rate by more than 50%, which has had a significant impact on our overall productivity, while improving our service to physicians. In addition, we have doubled our laboratory services without any increase in staff," stated Gloria Wilkerson, Clinical Laboratory Manager with Shands Hospital Rocky Point Core Laboratory in Gainsville, FL.
"The ADVIA 2120 was designed to reduce manual test procedures, patient sample size and costly repeats while maximizing laboratory resources and minimizing workspace. Innovations such as internal verification on every sample, by comparing the results using two different methodologies, ensures laboratorian’s confidence in the test results. Such features provide unique quality control not seen in other routine hematology analyzers -- aiding the physician in diagnosis and treatment of various hematological disorders such as leukemia, platelet anomalies and red cell abnormalities", stated Hans Hiller, PhD, Senior Vice President of Bayer Diagnostics.
Additional process efficiencies are realized through integration with both the ADVIA CentraLink® which provides laboratory network solutions, and with the ADVIA® Autoslide* later this year -- expanding Bayer’s practical automation solution for hematology. Optional MultiSpecies software* will also be available on the ADVIA 2120 to expand laboratory testing to the veterinary and research laboratories.
[此贴子已经被作者于2005-3-24 23:03:28编辑过]
|